Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children

PURPOSE: To report the efficacy of subconjunctival triamcinolone (Kenalog A-40, Alcon) and bevacizumab (Avastin, Genentech) injections in fraternal twins with blepharokeratoconjunctivitis (BKC) causing progressive, bilateral corneal neovascularization and scarring. METHODS: In this retrospective obs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Ophthalmol Med
Autors principals: Nguyen, Chu Luan, Chen, Tony S., Tran, Khoi, Smith, James E. H., Lewis, Noni
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6008772/
https://ncbi.nlm.nih.gov/pubmed/29967706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2602487
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars